Why the Bubs Australia Ltd share price has rocketed 27% today

The Bubs Australia Ltd (ASX:BUB) share price has been a big mover on the share market today. Its shares are up 26% in morning trade, here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price has been one of the biggest movers on the Australian share market today.

In morning trade the infant formula and baby food company's shares are up a whopping 27% to 16.5 cents.

Why has Bubs rocketed?

As well as announcing a new CEO this morning, Bubs announced a significant agreement with Brilite Nutritionals to be an exclusive partner and authorised distributor in China.

Founder and executive director Kristy Carr believes it is a ground-breaking agreement which will ultimately lead to its products being sold in over 2,000 mother and baby stores across China.

Furthermore, the company believes the deal with Brilite provides Bubs with a distribution capability vastly superior to traditional models that its rivals have typically used in China.

According to the release, in the short term Brilite will help finalise regulatory approvals for all its products. In the long-term it will assist Bubs with the development of new products for the China market.

Should you invest?

This is undoubtedly promising news for the fledgling company and I'm not surprised to see its shares rally today.

As we have seen with a2 Milk Company Ltd (Australia) (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL), there is an insatiable demand from Chinese consumers for Australian infant formula.

If Bubs can capture some of this demand through this partnership then it stands to benefit greatly.

But it is a fiercely competitive market and wide distribution does not necessarily mean guaranteed success.

For this reason I would suggest investors keep Bubs on their watchlist for now and wait for sales data when it becomes available.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »